DrugMonitor™ Anti-Lilotomab Antibody (VS-1224-YC669)
CAT#: VS-1224-YC669
Lilotomab (formerly tetulomab, HH1) is a murine monoclonal antibody targeting CD37, under investigation for relapsed non-Hodgkin lymphoma treatment. The DrugMonitor™ Anti-Lilotomab Antibody (VS-1224-YC669) is an anti-drug antibody (ADA) against Lilotomab. This drug-based antibody is raised in mice immunized with the Lilotomab. The anti-Lilotomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Lilotomab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Lilotomab
- Target
- Lilotomab
- Immunogen
- Lilotomab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Lilotomab
- Related Disease
- Relapsed non-Hodgkin lymphoma treatment
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC669. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "Lilotomab"
Anti-Human CD37 Recombinant Antibody (Lilotomab)Recombinant monoclonal antibody to CD37. Lilotomab is a mouse monoclonal antibody that can be potentially used in the treatment of Non-Hodgkin's lymphoma (NHL).
Afuco™ Anti-CD37 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-467CQ)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD37. It is a mouse monoclonal antibody that can be potentially used in the treatment of Non-Hodgkin's lymphoma (NHL).
Popular Products
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: WB, IHC, FC, Cyt, ELISA
Application: ELISA
Application: FC, IB, Block, Inhib, FuncS, ELISA, FACS, IP, IF
Application: ELISA, WB, Neut, Funcs, IHC, Inhib
Application: FC, FRET, Internalization
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, FC, Inhib, FuncS
Application: ELISA, PD, Activ, PK, Stim
Application: FC, FuncS, IA, IF, IP, IHC
Application: ELISA, FC, Neut, Inhib
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.